Despite Insecurity, UNICEF Measles Campaign In Somalia Reaches Over 142,000

Despite Insecurity, UNICEF Measles Campaign In Somalia Reaches Over 142,000
UNICEF announced that 142,654 children between the ages of 9 months and 15 years were vaccinated against measles in the latest campaign carried out in Mogadishu and Afgoye Internally Displaced Persons (IDP) camps in Central Somalia between 27 August and 4 September 2008.

Trius Doses First Patient In Antibacterial Phase 2 Trial - TR-701 Tested For Efficacy In Drug Resistant Skin Infections
Trius Therapeutics, Inc. announced the initiation of Phase 2 testing of the oral form of its second-generation oxazolidinone antibacterial drug TR- 701. The multicenter trial will test the efficacy, safety and tolerability of once- daily doses of 200, 300 and 400 milligrams of TR-701 in complicated skin and skin structure infections (cSSSI) for five to seven days of treatment.

New Data To Inform Clinical Practice Around Preterm Labour
For the first time clinicians will be provided with evidence on the long-term effects on children of using antibiotics in women at risk of giving birth early. The research consists of the seven-year follow up of a clinical trial, ORACLE, into the use of antibiotics in women presenting with signs of premature labour without obvious infection. The evidence obtained is crucial to ensuring women in these difficult circumstances receive the best clinical care for themselves and their babies.